Bromine in PDB 7rde: Human Triose Phosphate Isomerase Q181P
Enzymatic activity of Human Triose Phosphate Isomerase Q181P
All present enzymatic activity of Human Triose Phosphate Isomerase Q181P:
4.2.3.3;
5.3.1.1;
Protein crystallography data
The structure of Human Triose Phosphate Isomerase Q181P, PDB code: 7rde
was solved by
A.P.Vandemark,
J.Kowalski,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
35.33 /
1.31
|
Space group
|
P 21 21 21
|
Cell size a, b, c (Å), α, β, γ (°)
|
73.189,
77.822,
84.295,
90,
90,
90
|
R / Rfree (%)
|
13.7 /
16.2
|
Other elements in 7rde:
The structure of Human Triose Phosphate Isomerase Q181P also contains other interesting chemical elements:
Bromine Binding Sites:
The binding sites of Bromine atom in the Human Triose Phosphate Isomerase Q181P
(pdb code 7rde). This binding sites where shown within
5.0 Angstroms radius around Bromine atom.
In total 2 binding sites of Bromine where determined in the
Human Triose Phosphate Isomerase Q181P, PDB code: 7rde:
Jump to Bromine binding site number:
1;
2;
Bromine binding site 1 out
of 2 in 7rde
Go back to
Bromine Binding Sites List in 7rde
Bromine binding site 1 out
of 2 in the Human Triose Phosphate Isomerase Q181P
Mono view
Stereo pair view
|
A full contact list of Bromine with other atoms in the Br binding
site number 1 of Human Triose Phosphate Isomerase Q181P within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Br301
b:12.1
occ:0.60
|
HE2
|
A:HIS95
|
2.5
|
12.7
|
1.0
|
HD22
|
A:ASN11
|
2.7
|
11.8
|
1.0
|
HG
|
A:LEU230
|
3.0
|
13.9
|
1.0
|
HB3
|
A:ASN11
|
3.0
|
11.0
|
1.0
|
O
|
A:HOH448
|
3.1
|
28.6
|
1.0
|
O
|
A:HOH571
|
3.1
|
29.9
|
1.0
|
HE2
|
A:LYS13
|
3.2
|
14.7
|
1.0
|
HE3
|
A:LYS13
|
3.3
|
14.7
|
1.0
|
NE2
|
A:HIS95
|
3.4
|
10.6
|
1.0
|
HA2
|
A:GLY232
|
3.4
|
12.9
|
1.0
|
ND2
|
A:ASN11
|
3.5
|
9.8
|
1.0
|
HA3
|
A:GLY232
|
3.6
|
12.9
|
1.0
|
CE
|
A:LYS13
|
3.6
|
12.3
|
1.0
|
HZ3
|
A:LYS13
|
3.7
|
17.6
|
1.0
|
CB
|
A:ASN11
|
3.7
|
9.2
|
1.0
|
CA
|
A:GLY232
|
3.8
|
10.8
|
1.0
|
HB2
|
A:ASN11
|
3.8
|
11.0
|
1.0
|
HD23
|
A:LEU230
|
3.8
|
16.0
|
1.0
|
N
|
A:GLY232
|
3.9
|
10.6
|
1.0
|
CG
|
A:LEU230
|
3.9
|
11.6
|
1.0
|
HD21
|
A:LEU230
|
3.9
|
16.0
|
1.0
|
HD21
|
A:ASN11
|
4.0
|
11.8
|
1.0
|
CG
|
A:ASN11
|
4.1
|
8.9
|
1.0
|
CD2
|
A:LEU230
|
4.1
|
13.3
|
1.0
|
C
|
A:VAL231
|
4.1
|
10.4
|
1.0
|
H
|
A:GLY232
|
4.1
|
12.7
|
1.0
|
HD2
|
A:HIS95
|
4.2
|
12.3
|
1.0
|
O
|
A:LEU230
|
4.2
|
11.2
|
1.0
|
CD2
|
A:HIS95
|
4.2
|
10.3
|
1.0
|
NZ
|
A:LYS13
|
4.2
|
14.6
|
1.0
|
O
|
A:VAL231
|
4.3
|
11.9
|
1.0
|
CE1
|
A:HIS95
|
4.4
|
10.3
|
1.0
|
HE1
|
A:HIS95
|
4.5
|
12.4
|
1.0
|
H
|
A:GLY210
|
4.5
|
19.2
|
1.0
|
C
|
A:LEU230
|
4.5
|
10.0
|
1.0
|
O
|
A:HOH403
|
4.6
|
37.4
|
1.0
|
HB3
|
A:LEU230
|
4.6
|
12.1
|
1.0
|
O
|
A:HOH481
|
4.6
|
17.2
|
1.0
|
HD11
|
A:LEU230
|
4.7
|
14.5
|
1.0
|
HZ2
|
A:LYS13
|
4.8
|
17.6
|
1.0
|
N
|
A:VAL231
|
4.8
|
9.6
|
1.0
|
H
|
A:ASN11
|
4.8
|
10.6
|
1.0
|
CB
|
A:LEU230
|
4.8
|
10.1
|
1.0
|
CD1
|
A:LEU230
|
4.8
|
12.1
|
1.0
|
HZ1
|
A:LYS13
|
4.8
|
17.6
|
1.0
|
HD12
|
A:LEU230
|
4.8
|
14.5
|
1.0
|
OE2
|
A:GLU165
|
4.9
|
15.8
|
1.0
|
HG2
|
A:LYS13
|
4.9
|
11.9
|
1.0
|
HG3
|
A:LYS13
|
4.9
|
11.9
|
1.0
|
CA
|
A:VAL231
|
5.0
|
9.4
|
1.0
|
|
Bromine binding site 2 out
of 2 in 7rde
Go back to
Bromine Binding Sites List in 7rde
Bromine binding site 2 out
of 2 in the Human Triose Phosphate Isomerase Q181P
Mono view
Stereo pair view
|
A full contact list of Bromine with other atoms in the Br binding
site number 2 of Human Triose Phosphate Isomerase Q181P within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Br302
b:20.1
occ:0.45
|
HE2
|
B:HIS95
|
2.5
|
15.1
|
1.0
|
HD22
|
B:ASN11
|
2.5
|
14.0
|
1.0
|
O
|
B:HOH487
|
2.7
|
23.3
|
1.0
|
HB3
|
B:ASN11
|
2.9
|
12.8
|
1.0
|
O
|
B:HOH454
|
3.0
|
28.9
|
1.0
|
HG
|
B:LEU230
|
3.1
|
14.9
|
1.0
|
HE2
|
B:LYS13
|
3.2
|
17.3
|
1.0
|
HE3
|
B:LYS13
|
3.3
|
17.3
|
1.0
|
ND2
|
B:ASN11
|
3.3
|
11.7
|
1.0
|
NE2
|
B:HIS95
|
3.3
|
12.6
|
1.0
|
HA2
|
B:GLY232
|
3.3
|
16.2
|
1.0
|
CB
|
B:ASN11
|
3.6
|
10.7
|
1.0
|
HB2
|
B:ASN11
|
3.6
|
12.8
|
1.0
|
CE
|
B:LYS13
|
3.7
|
14.4
|
1.0
|
HA3
|
B:GLY232
|
3.7
|
16.2
|
1.0
|
HZ1
|
B:LYS13
|
3.8
|
18.2
|
1.0
|
CA
|
B:GLY232
|
3.8
|
13.5
|
1.0
|
HD21
|
B:ASN11
|
3.9
|
14.0
|
1.0
|
HD23
|
B:LEU230
|
3.9
|
16.8
|
1.0
|
CG
|
B:ASN11
|
3.9
|
10.9
|
1.0
|
N
|
B:GLY232
|
3.9
|
12.7
|
1.0
|
CG
|
B:LEU230
|
4.0
|
12.4
|
1.0
|
HD21
|
B:LEU230
|
4.0
|
16.8
|
1.0
|
HD2
|
B:HIS95
|
4.1
|
15.1
|
1.0
|
O
|
B:LEU230
|
4.1
|
12.8
|
1.0
|
C
|
B:VAL231
|
4.1
|
12.4
|
1.0
|
O
|
B:VAL231
|
4.1
|
13.5
|
1.0
|
CD2
|
B:HIS95
|
4.1
|
12.6
|
1.0
|
CD2
|
B:LEU230
|
4.2
|
14.0
|
1.0
|
NZ
|
B:LYS13
|
4.3
|
15.1
|
1.0
|
H
|
B:GLY232
|
4.3
|
15.3
|
1.0
|
OE2
|
B:GLU165
|
4.3
|
31.8
|
1.0
|
CE1
|
B:HIS95
|
4.4
|
11.9
|
1.0
|
O
|
B:HOH590
|
4.5
|
33.1
|
1.0
|
HE1
|
B:HIS95
|
4.5
|
14.3
|
1.0
|
C
|
B:LEU230
|
4.5
|
11.1
|
1.0
|
HB3
|
B:LEU230
|
4.6
|
13.5
|
1.0
|
H
|
B:ASN11
|
4.7
|
11.5
|
1.0
|
HG3
|
B:LYS13
|
4.8
|
13.7
|
1.0
|
HZ3
|
B:LYS13
|
4.8
|
18.2
|
1.0
|
HG2
|
B:LYS13
|
4.8
|
13.7
|
1.0
|
CB
|
B:LEU230
|
4.8
|
11.2
|
1.0
|
HZ2
|
B:LYS13
|
4.9
|
18.2
|
1.0
|
HG1
|
A:THR75
|
4.9
|
13.5
|
1.0
|
HD11
|
B:LEU230
|
4.9
|
15.5
|
1.0
|
O
|
B:GLY209
|
4.9
|
15.6
|
1.0
|
N
|
B:VAL231
|
4.9
|
11.5
|
1.0
|
CA
|
B:ASN11
|
4.9
|
10.3
|
1.0
|
CD1
|
B:LEU230
|
4.9
|
12.9
|
1.0
|
CD
|
B:LYS13
|
5.0
|
12.9
|
1.0
|
O
|
B:ASN11
|
5.0
|
11.2
|
1.0
|
|
Reference:
A.P.Vandemark,
S.L.Hrizo,
S.L.Eicher,
J.Kowalski,
T.D.Myers,
M.R.Pfeifer,
K.N.Riley,
D.D.Koeberl,
M.J.Palladino.
Itavastatin and Resveratrol Increase Triosephosphate Isomerase Protein in A Newly Identified Variant of Tpi Deficiency. Dis Model Mech V. 15 2022.
ISSN: ISSN 1754-8411
PubMed: 35315486
DOI: 10.1242/DMM.049261
Page generated: Thu Jul 11 04:30:53 2024
|